Baraclude and Itching - a phase IV clinical study of FDA data

Summary:

Itching is reported as a side effect among people who take Baraclude (entecavir), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Twynsta, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Itching when taking Baraclude. It is created by eHealthMe based on reports of 6,115 people who have side effects when taking Baraclude from the FDA, and is updated regularly.

What is Baraclude?

Baraclude has active ingredients of entecavir. It is often used in hepatitis b. eHealthMe is studying from 6,175 Baraclude users. Check the latest studies of Baraclude.

What is Itching?

Itching is found to be associated with 3,211 drugs and 4,537 conditions by eHealthMe. Check the latest studies of Itching.

On Jul, 26, 2026

6,115 people reported to have side effects when taking Baraclude.
Among them, 60 people (0.98%) have Itching.

Among these 60 people:

How long have people been on Baraclude when they have Itching? *

What is the gender of people who have Itching when taking Baraclude? *

female: 28.57 %
male: 71.43 %

What is the age of people who have Itching when taking Baraclude? *

What are other drugs people take besides Baraclude? *

What are other side effects people have besides Itching? *

Rashes (redness): 15 people, 25.00%
Diarrhea: 7 people, 11.67%
Dyspnea (difficult or laboured breathing): 5 people, 8.33%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 5 people, 8.33%
Fatigue (feeling of tiredness): 5 people, 8.33%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 6.67%
Headache (pain in head): 4 people, 6.67%
Dry Skin: 4 people, 6.67%
Insomnia (sleeplessness): 4 people, 6.67%
Oedema Peripheral (superficial swelling): 4 people, 6.67%

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 8.33%
High Blood Pressure: 4 people, 6.67%
Hepatocellular Carcinoma (liver cancer): 4 people, 6.67%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 3 people, 5.00%
Ascites (accumulation of fluid in the abdominal cavity): 3 people, 5.00%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 3 people, 5.00%
Hepatitis C: 3 people, 5.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 5.00%
Portal Hypertension (increase in the blood pressure within a system of veins called the portal venous system): 3 people, 5.00%
High Blood Cholesterol: 2 people, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Baraclude and have Itching?

- Check whether Itching is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Baraclude:

Baraclude (6,175 reports)

Itching treatments and more:

Itching (398,822 reports)

Browse all side effects of Baraclude:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Itching:

Itching (3,211 drugs)

Browse all the conditions that are associated with Itching:

Itching (4,537 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on entecavir (the active ingredients of Baraclude) and Baraclude (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.